These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 25720804)
1. Effects of the angiotensin II Ala-scan analogs in erythrocytic cycle of Plasmodium falciparum (in vitro) and Plasmodium gallinaceum (ex vivo). Silva AF; de Souza Silva L; Alves FL; Der TorossianTorres M; de SáPinheiro AA; Miranda A; LaraCapurro M; Oliveira VX Exp Parasitol; 2015 Jun; 153():1-7. PubMed ID: 25720804 [TBL] [Abstract][Full Text] [Related]
2. Angiotensin II restricted analogs with biological activity in the erythrocytic cycle of Plasmodium falciparum. Torres MD; Silva AF; de Souza Silva L; de Sá Pinheiro AA; Oliveira VX J Pept Sci; 2015 Jan; 21(1):24-8. PubMed ID: 25420772 [TBL] [Abstract][Full Text] [Related]
3. Highly potential antiplasmodial restricted peptides. Marcelo Der Torossian T; Silva AF; Alves FL; Capurro ML; Miranda A; Vani Xavier O Chem Biol Drug Des; 2015 Feb; 85(2):163-71. PubMed ID: 24800635 [TBL] [Abstract][Full Text] [Related]
4. New linear antiplasmodial peptides related to angiotensin II. Silva AF; Torres MD; Silva Lde S; Alves FL; Pinheiro AA; Miranda A; Capurro ML; Oliveira VX Malar J; 2015 Nov; 14():433. PubMed ID: 26537730 [TBL] [Abstract][Full Text] [Related]
5. Antiplasmodial activity study of angiotensin II via Ala scan analogs. Silva AF; Bastos EL; Torres MD; Costa-da-Silva AL; Ioshino RS; Capurro ML; Alves FL; Miranda A; Vieira Rde F; Oliveira VX J Pept Sci; 2014 Aug; 20(8):640-8. PubMed ID: 24817179 [TBL] [Abstract][Full Text] [Related]
6. Anti-plasmodial activity of bradykinin and analogs. Silva AF; Alves FL; Pedron CN; Torres MD; Silva LS; Pinheiro AA; Miranda A; Oliveira VX Bioorg Med Chem Lett; 2015 Aug; 25(16):3311-3. PubMed ID: 26077496 [TBL] [Abstract][Full Text] [Related]
7. A study of the anti-plasmodium activity of angiotensin II analogs. Chamlian M; Bastos EL; Maciel C; Capurro ML; Miranda A; Silva AF; Torres MD; Oliveira VX J Pept Sci; 2013 Sep; 19(9):575-80. PubMed ID: 23893516 [TBL] [Abstract][Full Text] [Related]
8. Evidences for the action mechanism of angiotensin II and its analogs on Plasmodium sporozoite membranes. Torres MD; Silva AF; Alves FL; Capurro ML; Miranda A; Cordeiro RM; Oliveira Junior VX J Pept Sci; 2016 Mar; 22(3):132-42. PubMed ID: 26856687 [TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction. Silva AF; Torres MT; Silva LS; Alves FL; de Sá Pinheiro AA; Miranda A; Capurro ML; de la Fuente-Nunez C; Oliveira VX Sci Rep; 2017 Oct; 7(1):14326. PubMed ID: 29085013 [TBL] [Abstract][Full Text] [Related]
10. Impairment of the Plasmodium falciparum erythrocytic cycle induced by angiotensin peptides. Saraiva VB; de Souza Silva L; Ferreira-DaSilva CT; da Silva-Filho JL; Teixeira-Ferreira A; Perales J; Souza MC; Henriques Md; Caruso-Neves C; de Sá Pinheiro AA PLoS One; 2011 Feb; 6(2):e17174. PubMed ID: 21364758 [TBL] [Abstract][Full Text] [Related]
11. Anti-plasmodium activity of angiotensin II and related synthetic peptides. Maciel C; de Oliveira Junior VX; Fázio MA; Nacif-Pimenta R; Miranda A; Pimenta PF; Capurro ML PLoS One; 2008 Sep; 3(9):e3296. PubMed ID: 18820728 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo. Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754 [TBL] [Abstract][Full Text] [Related]
15. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum. Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941 [TBL] [Abstract][Full Text] [Related]
16. New syntheses and potential antimalarial activities of new 'retinoid-like chalcones'. Valla A; Valla B; Cartier D; Le Guillou R; Labia R; Florent L; Charneau S; Schrevel J; Potier P Eur J Med Chem; 2006 Jan; 41(1):142-6. PubMed ID: 16274873 [TBL] [Abstract][Full Text] [Related]
17. Synthetic indole and melatonin derivatives exhibit antimalarial activity on the cell cycle of the human malaria parasite Plasmodium falciparum. Schuck DC; Jordão AK; Nakabashi M; Cunha AC; Ferreira VF; Garcia CR Eur J Med Chem; 2014 May; 78():375-82. PubMed ID: 24699367 [TBL] [Abstract][Full Text] [Related]
18. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antimalarial activity of new 3-arylquinoxaline-2-carbonitrile derivatives. Zarranz B; Jaso A; Aldana I; Monge A; Maurel S; Deharo E; Jullian V; Sauvain M Arzneimittelforschung; 2005; 55(12):754-61. PubMed ID: 16430030 [TBL] [Abstract][Full Text] [Related]
20. Sulfated cyclodextrins inhibit the entry of Plasmodium into red blood cells. Implications for malarial therapy. Crandall IE; Szarek WA; Vlahakis JZ; Xu Y; Vohra R; Sui J; Kisilevsky R Biochem Pharmacol; 2007 Mar; 73(5):632-42. PubMed ID: 17166484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]